diabetes
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
October 23, 2026Diabetes, Obesity, Peptide therapies, clinical trials, diabetes, weight reduction
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults …
First 90 days of antipsychotic treatment linked to rapid metabolic changes
October 20, 2026Diabetes, NIHR, Psychiatry, UCL, antipsychotic drugs, diabetes, mental health, mental illness
The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood glucose and weight, according to …
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
October 6, 2026Diabetes, GLP-1, Obesity, diabetes, obesity, phase 3 trial
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in people with obesity or overweight …
Study to examine ways of improving diabetes care for younger adults
June 16, 2026diabetes
Researchers at Northumbria University are leading a £1.3m study aimed at helping GP practices improve care for young adults living …
MetP Pharma releases positive data on intranasal semaglutide administration
July 22, 2025Research and Development Diabetes, MetP Pharma, Neurology, Obesity, central nervous system, diabetes, obesity, peptides, semaglutide
MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering neuroactive peptides, particularly semaglutide, directly …
AOTI diabetic foot care therapy to be used by NHS
April 23, 2025Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study
Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …
Recce Pharmaceuticals reports positive phase 2 data for skin infection drug
February 17, 2025Research and Development Recce, Skin, diabetes, skin, skin infections
Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment …
Roche gains CE Mark for AI glucose monitoring system for diabetes management
July 9, 2024Medical Communications AI, Diabetes, Roche, diabetes, glucose monitoring
Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution.
Vertex shares results from phase 1/2 trial of type 1 diabetes treatment
June 24, 2024Research and Development Diabetes, Vertex pharmaceuticals, clinical trial, diabetes
Vertex Pharmaceuticals has announced new data from its phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated …
CHMP recommends Novo Nordisk’s Awiqli for diabetes treatment
March 22, 2024Medical Communications CHMP, Diabetes, Novo Nordisk, diabetes
Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended …
Roche shares data on novel solution for continuous glucose monitoring
March 8, 2024Research and Development Diabetes, Medical device, Roche, continuous glucose monitoring, diabetes
Roche has shared the latest data on its novel solution for continuous glucose monitoring (CGM), including a CGM sensor and …
Novo Nordisk shares positive results from COMBINE 3 phase 3a trial
January 10, 2024Research and Development Diabetes, IcoSema, Novo Nordisk, clinical trial, diabetes
Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly IcoSema, a fixed-ration combination treatment …
Eli Lilly launches digital healthcare process
January 5, 2024Medical Communications Diabetes, Eli Lilly, Obesity, diabetes, obesity
Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine …
Roche to acquire Carmot Therapeutics for $2.7bn
December 4, 2023Business Services Obesity, Roche, acquisition, diabetes
Roche has announced that it has entered into a definitive merger agreement with Carmot Therapeutics, in which it will acquire …
Abbott to acquire Bigfoot Biomedical
September 6, 2023Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
